Novo Nordisk (NVO) is trading at $41.20 after a 2.67% drop, with price sitting just above immediate support at $40.79 and near the 7-day moving average. The setup is mixed: the broader moving-avera...
Novo Nordisk (NVO) closed the latest session at $41.20, down 2.67% on the day, with the 24-hour range running from $42.35 to $41.16. That puts the stock just above immediate support at $40.79 and close to the 7-day simple moving average at $41.21, so this is more of a pullback into a support band than a clean momentum breakdown.
The broader structure is still constructive. The moving-average stack remains bullish, with the 20-day SMA at $40.67 and the 50-day SMA at $39.34, both below spot. That matters because price is still holding above the mid-band of the Bollinger setup at $40.67, while the upper band sits at $42.07.
The daily RSI of 56.13 is neutral-to-firm, which tells you NVO is not overextended even after the recent slip. MACD is flat to slightly bearish on the supplied reading, with the MACD line and signal both at 0.5133 and the histogram at 0.0000. That is not a strong bearish impulse, but it does show momentum has paused rather than accelerated higher.
Stochastic readings are also middling, with %K at 41.91 and %D at 33.53. In plain terms, the tape is not oversold, but it also is not flashing a fresh upside breakout.
The derivatives tape is where the message gets more interesting. 99 contracts, with daily open interest value at $930,251.
Source link







